Comparison of outcomes of KPC-producing Enterobacterales bloodstream infections treated with ceftazidime-avibactam and other conventional antibiotics: retrospective single-center study

ABSTRACT Ceftazidime–avibactam (CZA) was introduced in South Korea in July 2023, but regional data on its clinical efficacy, treatment outcomes, and microbiological characteristics of bloodstream infections (BSIs) caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacterales remain...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kyungsup Kwon, So Yun Lim, Euijin Chang, Seongman Bae, Min Jae Kim, Yong Pil Chong, Sung-Han Kim, Sang-Ho Choi, Sang-Oh Lee, Yang Soo Kim, Jiwon Jung
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology 2026-04-01
Serie:	Microbiology Spectrum
Soggetti:	carbapenemase-producing Enterobacterales Klebsiella pneumoniae carbapenemase ceftazidime-avibactam
Accesso online:	https://journals.asm.org/doi/10.1128/spectrum.02819-25
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!